Daping Hospital And The Research Institute Of Surgery Of The Third Military Medical University
Clinical trials sponsored by Daping Hospital And The Research Institute Of Surgery Of The Third Military Medical University, explained in plain language.
-
New Radiation-Immunotherapy combo tested for advanced colon cancer
Disease control Recruiting nowThis early-stage trial is testing whether a combination of low-dose radiation, chemotherapy, and immunotherapy is safe and feasible for people with colorectal cancer that has spread only to the liver. The study will enroll 9-18 participants who have not had prior cancer treatment…
Phase: PHASE1 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Apr 03, 2026 23:05 UTC
-
Breathing machine battle: which method best protects premature Babies' lungs?
Disease control Recruiting nowThis study aims to find out which of two breathing machine methods works better for very premature babies who develop severe lung distress shortly after birth. Researchers will compare a high-frequency vibrating method against the standard method in 400 babies born between 24 and…
Phase: NA • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New combo therapy aims to shrink stomach tumors before surgery
Disease control Recruiting nowThis study is testing a combination of radiation, chemotherapy, and two immunotherapy drugs given before surgery for stomach cancer. The goal is to see if this approach can shrink or eliminate the tumor to make surgery more successful. Researchers will compare two different order…
Phase: PHASE2 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug combo aims to shrink tough colon tumors before surgery
Disease control Recruiting nowThis study is testing if adding a new drug called tolecizumab to standard pre-surgery treatment can better shrink tumors in patients with locally advanced colon cancer. About 106 patients will be randomly assigned to receive either the new combination or the standard treatment al…
Phase: PHASE2 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New robotic surgery technique tested for colon cancer patients
Disease control Recruiting nowThis study compares two types of robotic surgery for rectal cancer: one using a single small incision versus the standard method using several small incisions. Researchers want to see if the single-incision approach is as safe and effective, focusing on surgery complications, rec…
Phase: NA • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New brain scan aims to pinpoint deadly Tumor's genetic fingerprint
Diagnosis Recruiting nowThis study is testing a new combined PET/MRI brain scan designed to detect a specific genetic mutation (IDH) in gliomas, a common and often aggressive type of brain tumor. The goal is to see if this non-invasive scan can accurately identify the tumor's subtype, which helps doctor…
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Diagnosis
Last updated Mar 31, 2026 12:12 UTC